invest in such products should proceed with extra caution since:(1) The product above has not been screened with regard to its qualifications and smart contracts by SEC-approved ICO portals; (2
compliance with the governing law; (2) These ICOs have not been screened by the SEC-approved ICO portals; (3) Necessary and sufficient information on these ICOs may not be disclosed to support investors
products due to the following reasons: (1) Those products above are not digital assets approved by SEC under the governing law; (2) Those products above have not been screened with regard to their
governing law; (2) These ICOs have not been screened by the SEC-approved ICO portals; (3) Necessary and sufficient information on these ICOs may not be disclosed to support investors’ decision making; (4
assets approved by SEC under the governing law; (2) Those products above have not been screened with regard to their qualifications and smart contracts by SEC-approved ICO portals; (3) There might
2020 To : The President The Stock Exchange of Thailand Bangkok Chain Hospital Public Company Limited (the “Company”) would like to report the operating results for the first quarter ended 31 March 2020
Derivative Warrants | NIKKEI41P2409A | DERIVATIVE PUT WARRANTS ON NIKKEI 225 STOCK AVERAGE INDEX ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN SEPTEMBER 2024 # A | NIKKEI 225 STOCK
Derivative Warrants | NIKKEI41C2412T | DERIVATIVE CALL WARRANTS ON NIKKEI 225 STOCK AVERAGE INDEX ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN DECEMBER 2024 # T | NIKKEI 225 STOCK
Derivative Warrants | NIKKEI41C2409A | DERIVATIVE CALL WARRANTS ON NIKKEI 225 STOCK AVERAGE INDEX ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN SEPTEMBER 2024 # A | NIKKEI 225
Derivative Warrants | NIKKEI41P2412T | DERIVATIVE PUT WARRANTS ON NIKKEI 225 STOCK AVERAGE INDEX ISSUED BY JPMORGAN SECURITIES (THAILAND) LIMITED LAST TRADING IN DECEMBER 2024 # T | NIKKEI 225 STOCK